Maastricht University
Maastricht, Limburg, 6229ER, Netherlands
NCT Number: NCT05784207
The purpose of this study is to compare AI performance to doctor's performance in the evaluation of IPF/UIP and ILDs without UIP(proven by biopsy).
Looking for future studies?
Notify MeAll sexes
Observational
Maastricht, Limburg, 6229ER, Netherlands
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The aim is to evaluate the performance of AI with the performance of doctors
Time frame: May 2021
Reporting the performance measure: accuracy
Time frame: June 2021
Correctness of the diagnosis - the most probable thin-section pattern (dichotomous outcome: yes or no)
Time frame: June 2021
Correctness of the diagnosis - the most probable thin-section pattern (dichotomous outcome: yes or no)
Time frame: June 2021
Measuring the concordance in diagnosis in between the physicians, and for each physician separately, using the Concordance correlation coefficient.
Maastricht University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07712952
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Seoul, South Korea
View Trial DetailsNCT04708782
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Birmingham, Alabama, United States
View Trial DetailsNCT05255991
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
View Trial DetailsNCT02036970
Acute Interstitial Pneumonitis, Bronchial Diseases
Phoenix, Arizona, United States
View Trial Details